Literature DB >> 30787503

Effect of Early Mobility as a Physiotherapy Treatment for Pneumonia: A Systematic Review and Meta-Analysis.

Tania Larsen1,2, Annemarie Lee3,4, Dina Brooks5, Stephanie Michieli1, Meaghan Robson1, Jenna Veens1, Olivia Vokes1, S Deborah Lucy1.   

Abstract

Purpose: We conducted a systematic review of the effect of early mobility on length of stay (LOS), mortality, and clinical outcomes as a treatment for adults hospitalized with pneumonia. Method: An electronic search of four databases was conducted. Inclusion criteria were (1) acute medical condition of pneumonia in adults and (2) early mobility intervention. Quality appraisal was conducted using the Physiotherapy Evidence Database scale and the Newcastle-Ottawa Scale.
Results: Four studies (three randomized controlled trials and one retrospective cohort study) met the inclusion criteria. Meta-analysis demonstrated that early mobility did not reduce the risk of mortality compared with usual care (risk ratio 0.9 [95% CI: 0.27, 2.97]; p = 0.86) but did reduce the mean LOS (-1.1 days [95% CI: 2.21, -0.04]; p = 0.04). Early mobility also did not affect the rate of hospital readmissions or emergency department visits. One study demonstrated an improvement in functional exercise capacity and quality of life related to physical function and faster completion of a measure of activities of daily living. Conclusions: Early mobility reduced LOS in adults hospitalized with community-acquired pneumonia, although there was no effect on mortality or rate of hospital readmissions. Further research is needed to determine the effect of early mobility in this population and establish guidelines.

Entities:  

Keywords:  early mobilization; hospitalization; pneumonia; systematic review; treatment

Year:  2019        PMID: 30787503      PMCID: PMC6373606          DOI: 10.3138/ptc.2017-51.ep

Source DB:  PubMed          Journal:  Physiother Can        ISSN: 0300-0508            Impact factor:   1.037


  24 in total

1.  Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).

Authors:  C M Kozma; M Dickson; M K Raut; S Mody; A C Fisher; J R Schein; J I Mackowiak
Journal:  J Med Econ       Date:  2010-11-22       Impact factor: 2.448

Review 2.  Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review.

Authors:  Jonathan S Lee; Daniel L Giesler; Walid F Gellad; Michael J Fine
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  ICU early mobilization: from recommendation to implementation at three medical centers.

Authors:  Heidi J Engel; Dale M Needham; Peter E Morris; Michael A Gropper
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

5.  Modern Management of Community-Acquired Pneumonia: Is It Cost-Effective and are Outcomes Acceptable?

Authors:  Dominik Mertz; Jennie Johnstone
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

6.  Early mobilization of patients hospitalized with community-acquired pneumonia.

Authors:  Linda M Mundy; Terry L Leet; Kate Darst; Mark A Schnitzler; William Claiborne Dunagan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment.

Authors:  H Kothe; T Bauer; R Marre; N Suttorp; T Welte; K Dalhoff
Journal:  Eur Respir J       Date:  2008-02-20       Impact factor: 16.671

8.  The incidence rate and economic burden of community-acquired pneumonia in a working-age population.

Authors:  Jonah Broulette; Holly Yu; Bruce Pyenson; Kosuke Iwasaki; Reiko Sato
Journal:  Am Health Drug Benefits       Date:  2013-09

9.  Effect of early rehabilitation by physical therapists on in-hospital mortality after aspiration pneumonia in the elderly.

Authors:  Ryo Momosaki; Hideo Yasunaga; Hiroki Matsui; Hiromasa Horiguchi; Kiyohide Fushimi; Masahiro Abo
Journal:  Arch Phys Med Rehabil       Date:  2014-10-07       Impact factor: 3.966

10.  AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients.

Authors:  Shawna L Strickland; Bruce K Rubin; Gail S Drescher; Carl F Haas; Catherine A O'Malley; Teresa A Volsko; Richard D Branson; Dean R Hess
Journal:  Respir Care       Date:  2013-11-12       Impact factor: 2.258

View more
  5 in total

1.  Clinician's Commentary on Larsen et al.

Authors:  Erin Miller
Journal:  Physiother Can       Date:  2019       Impact factor: 1.037

2.  A novel early mobility bundle improves length of stay and rates of readmission among hospitalized general medicine patients.

Authors:  Emily Anne Smith Bergbower; Cole Herbst; Nan Cheng; Alexander Aversano; Katherine Pasqualini; Cierra Hartline; Devorah Hamby-Finkelstein; Colin Brewer; Stephen Benko; Joseph Fuscaldo
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-09-03

3.  A systematic review and meta-analysis of the effects of early mobilization therapy in patients after cardiac surgery.

Authors:  Bin Chen; Guanli Xie; Yuan Lin; Lianghua Chen; Zhichen Lin; Xiaofang You; Xuemin Xie; Danyu Dong; Xinyi Zheng; Dong Li; Wanqing Lin
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

Review 4.  Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic.

Authors:  Rashmi Supriya; Yang Gao; Yaodong Gu; Julien S Baker
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

5.  Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study.

Authors:  Hao Chen; Yu Hara; Nobuyuki Horita; Yusuke Saigusa; Yoshihiro Hirai; Takeshi Kaneko
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.